Precigen (NASDAQ: PGEN) CFO sells 100,000 shares in 10b5-1 plan

Rhea-AI Filing Summary

PRECIGEN, INC. Chief Financial Officer Harry Thomasian Jr. sold 100,000 shares of common stock on July 31, 2026 at a weighted average price of $6.06 per share, with trades between $6.00 and $6.15, under a Rule 10b5-1 trading plan. After the sale, he directly holds 254,535 shares.

Insider Trade Summary 10b5-1

Net Seller: 100,000 shares

Net Sell 1 txn

Insider Thomasian Harry Jr.

Role Chief Financial Officer

Sold 100,000 shs ($606K)

Type	Security	Shares	Price	Value
Sale	Common Stock F1, F2	100,000	$6.06	$606K

Holdings After Transaction: Common Stock — 254,535 shares (Direct)

Footnotes (2)

1. F1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.
2. F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

Key Figures

Shares sold: 100000.0000 shares Weighted average sale price: $6.0600 per share Post-transaction holdings: 254535.0000 shares +1 more

4 metrics

Shares sold 100000.0000 shares Common stock sale by CFO on July 31, 2026

Weighted average sale price $6.0600 per share Average price for the 100,000 shares sold on July 31, 2026

Post-transaction holdings 254535.0000 shares Common stock directly held by CFO after the reported sale

Sale price range $6.00–$6.15 per share Range of individual trade prices within the reported sale

Key Terms

Rule 10b5-1 plan, weighted average price, Sale in open market or private transaction

3 terms

Rule 10b5-1 plan financial

"Represents shares sold pursuant to the terms of a 10b5-1 plan adopted"

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

Sale in open market or private transaction financial

"transaction_code_description: Sale in open market or private transaction"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/31/2026 - 04:26 PM Accepted by SEC EDGAR 07/31/2026 - 04:26 PM Learn about SEC filing dates

FAQ

What insider transaction did Precigen (PGEN) disclose in this Form 4?

Precigen reported that its CFO, Harry Thomasian Jr., sold 100,000 shares of common stock on July 31, 2026. The transaction was reported as a sale in an open market or private transaction under a Rule 10b5-1 trading plan.

How many Precigen (PGEN) shares did the CFO retain after the reported sale?

Following the transaction, the CFO directly holds 254,535 shares of Precigen common stock. This post-transaction holding reflects the position after selling 100,000 shares on July 31, 2026, as disclosed in the Form 4 filing.

At what prices were the Precigen (PGEN) shares sold by the CFO?

The reported weighted average sale price was $6.06 per share. According to the filing, individual trades occurred in multiple transactions at prices ranging from $6.00 to $6.15 per share, with full price-by-trade detail available upon request.

Was the Precigen (PGEN) CFO’s sale made under a Rule 10b5-1 trading plan?

Yes. The filing states the 100,000 shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Such plans pre-arrange trades, which can limit the informational value of the transaction’s timing.

What type of security did the Precigen (PGEN) CFO sell in this transaction?

The transaction involved Common Stock of Precigen, Inc. The Form 4 identifies the security title as common stock, with 100,000 shares sold and 254,535 shares held directly by the CFO after completion of the sale.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Thomasian Harry Jr.

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MARYLAND 20876

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/31/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	07/31/2026		S(1)		100,000	D	$6.06(2)	254,535	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares sold pursuant to the terms of a 10b5-1 plan adopted by the reporting person.

2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.15, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.

	/s/ Harry Thomasian, Jr., by Donald P. Lehr, as attorney-in-fact	07/31/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)